EUVIMEDEUVIMED entdecken
Open Access

Ancillary Product Patents to Extend Biologic Patent Life

Rachel Goode, William B Feldman, S Sean Tu

JAMA · 05.12.2023 · 330 (21) · 2117

DOI: 10.1001/jama.2023.19547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 05.12.2023. Verfasst von Rachel Goode und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fresenius Kabi USA, Washington, DC. Hauptthemen laut MEDLINE: Biological Products, Biosimilar Pharmaceuticals, Patents as Topic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines all patents associated with biologic litigation to understand how manufacturers use ancillary product patents to delay biosimilar market entry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsBiosimilar PharmaceuticalsPatents as TopicDrug ApprovalDrug IndustryEconomic CompetitionUnited StatesTime Factors

Substanzen

Biological ProductsBiosimilar Pharmaceuticals

Autor:innen und Institutionen

  • Fresenius Kabi USA, Washington, DC.
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
  • West Virginia University College of Law, Morgantown.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Goode, R., Feldman, W. B., & Tu, S. S. (2023). Ancillary Product Patents to Extend Biologic Patent Life. JAMA, 330(21), 2117. https://doi.org/10.1001/jama.2023.19547

Vancouver

Goode R, Feldman WB, Tu SS. Ancillary Product Patents to Extend Biologic Patent Life. JAMA. 2023;330(21):2117. doi:10.1001/jama.2023.19547

BibTeX
@article{Goode2023,
  author = {Goode, Rachel and Feldman, William B and Tu, S Sean},
  title = {Ancillary Product Patents to Extend Biologic Patent Life},
  journal = {JAMA},
  year = {2023},
  volume = {330},
  number = {21},
  pages = {2117},
  doi = {10.1001/jama.2023.19547}
}
Kostenlos starten →